A Pilot study for Mobile Application-based Exercise Intervention and Nutrition Intervention for Cancer Patients with low muscle mass during chemotherapyNickname: SCONE (sarcopenia intervention for oncology patients with nutrition and exercise)

Asan Medical Center0 个研究点目标入组 30 人开始时间: 待定最近更新: 2024年4月2日

适应症

试验速览

暂无简介。

•1) Age 19 or older
•2) Patients with histologically confirmed solid cancer
•3) Planned or receiving palliative chemotherapy or neoadjuvant/adjuvant chemotherapy using two or more cytotoxic chemotherapy agents
•4) ECOG performance status 0-2
•5) If a basal abdominal CT (contrast CT must include the portal phase) that can confirm sarcopenia was taken within 4 weeks of participating in the study.
•6) Class I or class II sarcopenia with skeletal muscle index (=skeletal muscle area / BMI) T-score less than -1.0 measured by CT
•7) Life expectancy of more than 3 months
•8) Patients who can understand the research subject consent document and are willing to sign it

•1) Cases where there is a high risk of injury or fall during exercise intervention, such as bone metastasis, peripheral neuropathy, brain metastasis, etc.
•2) Cases where it is difficult to follow the exercise intervention of the mobile application due to cognitive decline, illiteracy, or severe hearing and vision impairment.
•3) If you do not have a smartphone
•4) Cases where protein intake is limited due to decreased renal function (eGFR <50mL/min/1.73m2)
•5) When the researcher determines that exercise and nutritional intervention are not best for the patient due to other clinical conditions.
•6) Over 80 years old

发起方